MUSTANG BIO INC's ticker is MBIO and the CUSIP is 62818Q104. A total of 72 filers reported holding MUSTANG BIO INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | – | 10 | -70.6% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 34 | -98.7% | 0.00% | – |
| Q1 2022 | $2,000 | -97.0% | 2,594 | -93.6% | 0.00% | – |
| Q4 2021 | $67,000 | +123.3% | 40,780 | +348.8% | 0.00% | – |
| Q3 2021 | $30,000 | -66.7% | 9,087 | -66.7% | 0.00% | – |
| Q2 2021 | $90,000 | +38.5% | 27,272 | +38.3% | 0.00% | – |
| Q1 2021 | $65,000 | -58.1% | 19,717 | -52.1% | 0.00% | – |
| Q4 2020 | $155,000 | +171.9% | 41,134 | +125.8% | 0.00% | – |
| Q3 2020 | $57,000 | – | 18,217 | +7960.6% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 226 | -98.9% | 0.00% | – |
| Q1 2020 | $55,000 | +1733.3% | 20,800 | +2115.1% | 0.00% | – |
| Q3 2019 | $3,000 | -82.4% | 939 | -80.3% | 0.00% | – |
| Q2 2019 | $17,000 | – | 4,765 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 125,000 | $336,000 | 0.45% |
| Spotlight Asset Group, Inc. | 305,312 | $821,000 | 0.41% |
| GSA CAPITAL PARTNERS LLP | 560,215 | $1,507,000 | 0.15% |
| Ikarian Capital, LLC | 506,033 | $1,360,000 | 0.10% |
| EMFO, LLC | 31,000 | $83,000 | 0.07% |
| Bridgewater Advisors Inc. | 45,000 | $121,000 | 0.03% |
| B. Riley Wealth Advisors, Inc. | 253,275 | $682,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 294,300 | $792,000 | 0.02% |
| TWO SIGMA ADVISERS, LP | 1,235,200 | $3,323,000 | 0.01% |
| Cypress Capital Management LLC (WY) | 2,950 | $8,000 | 0.01% |